289 related articles for article (PubMed ID: 32653467)
21. The use of recombinant human dornase alfa in CF.
Cox C
Paediatr Nurs; 1995 Nov; 7(9):29-31. PubMed ID: 8705343
[No Abstract] [Full Text] [Related]
22. Interventions for bronchiectasis: an overview of Cochrane systematic reviews.
Welsh EJ; Evans DJ; Fowler SJ; Spencer S
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010337. PubMed ID: 26171905
[TBL] [Abstract][Full Text] [Related]
23. Airway clearance strategies in cystic fibrosis and non-cystic fibrosis bronchiectasis.
Main E; Grillo L; Rand S
Semin Respir Crit Care Med; 2015 Apr; 36(2):251-66. PubMed ID: 25826592
[TBL] [Abstract][Full Text] [Related]
24. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I.
King M; Dasgupta B; Tomkiewicz RP; Brown NE
Am J Respir Crit Care Med; 1997 Jul; 156(1):173-7. PubMed ID: 9230743
[TBL] [Abstract][Full Text] [Related]
25. Pharmacologic agents for mucus clearance in bronchiectasis.
Nair GB; Ilowite JS
Clin Chest Med; 2012 Jun; 33(2):363-70. PubMed ID: 22640851
[TBL] [Abstract][Full Text] [Related]
26. [Usefulness of mucoactive drugs in respiratory diseases].
Serrano J; Sanchis J
Arch Bronconeumol; 1998 Jan; 34(1):28-35. PubMed ID: 9522017
[No Abstract] [Full Text] [Related]
27. Expert group recommendation on inhaled mucoactive drugs in pediatric respiratory diseases: an Indian perspective.
Singh M; Varkki S; Kinimi I; Das RR; Goyal JP; Bhat M; Dayal R; Kalyan P; Gairolla J; Khosla I
Front Pediatr; 2023; 11():1322360. PubMed ID: 38111626
[TBL] [Abstract][Full Text] [Related]
28. Other mucoactive agents for cystic fibrosis.
Bye PT; Elkins MR
Paediatr Respir Rev; 2007 Mar; 8(1):30-9. PubMed ID: 17419976
[TBL] [Abstract][Full Text] [Related]
29. [Current therapeutic agents: dornase alfa].
Baran D; Sternon J
Rev Med Brux; 1997 Feb; 18(1):37-40. PubMed ID: 9132917
[TBL] [Abstract][Full Text] [Related]
30. Effects of recombinant human DNase and hypertonic saline on airway inflammation in children with cystic fibrosis.
Suri R; Marshall LJ; Wallis C; Metcalfe C; Bush A; Shute JK
Am J Respir Crit Care Med; 2002 Aug; 166(3):352-5. PubMed ID: 12153969
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological treatment options for bronchiectasis: focus on antimicrobial and anti-inflammatory agents.
Ilowite J; Spiegler P; Kessler H
Drugs; 2009; 69(4):407-19. PubMed ID: 19323585
[TBL] [Abstract][Full Text] [Related]
32. Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial.
Suri R; Metcalfe C; Lees B; Grieve R; Flather M; Normand C; Thompson S; Bush A; Wallis C
Lancet; 2001 Oct; 358(9290):1316-21. PubMed ID: 11684212
[TBL] [Abstract][Full Text] [Related]
33. Dornase-alfa (DNase, Pulmozyme) for cystic fibrosis.
MacConnachie AM
Intensive Crit Care Nurs; 1998 Apr; 14(2):101-2. PubMed ID: 9814214
[TBL] [Abstract][Full Text] [Related]
34. What is the cystic fibrosis clinician supposed to do with human recombinant dornase alfa?
Coates AL
J Pediatr; 2001 Dec; 139(6):768-70. PubMed ID: 11743499
[No Abstract] [Full Text] [Related]
35. Dornase alfa. A review of pharmacoeconomic and quality-of-life aspects of its use in cystic fibrosis.
Goa KL; Lamb H
Pharmacoeconomics; 1997 Sep; 12(3):409-22. PubMed ID: 10170464
[TBL] [Abstract][Full Text] [Related]
36. rhDNase in acute asthma.
Puterman AS; Weinberg EG
Pediatr Pulmonol; 1997 Apr; 23(4):316-7. PubMed ID: 9141119
[No Abstract] [Full Text] [Related]
37. Inhaled mannitol for cystic fibrosis.
Nevitt SJ; Thornton J; Murray CS; Dwyer T
Cochrane Database Syst Rev; 2020 May; 5(5):CD008649. PubMed ID: 32358807
[TBL] [Abstract][Full Text] [Related]
38. Inhaled mannitol for cystic fibrosis.
Nevitt SJ; Thornton J; Murray CS; Dwyer T
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD008649. PubMed ID: 29424930
[TBL] [Abstract][Full Text] [Related]
39. A case-controlled study with dornase alfa to evaluate impact on disease progression over a 4-year period.
Shah PL; Conway S; Scott SF; Rainisio M; Wildman M; Stableforth D; Hodson ME
Respiration; 2001; 68(2):160-4. PubMed ID: 11287830
[TBL] [Abstract][Full Text] [Related]
40. Nebulised bronchodilators, corticosteroids, and rhDNase in adult patients with cystic fibrosis.
Conway SP; Watson A
Thorax; 1997 Apr; 52 Suppl 2(Suppl 2):S64-8. PubMed ID: 9155855
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
